logo
VerticalScope Announces First Quarter 2025 Financial Results

VerticalScope Announces First Quarter 2025 Financial Results

Business Wire13-05-2025

TORONTO--(BUSINESS WIRE)--VerticalScope Holdings Inc. ('VerticalScope' or the 'Company') (TSX: FORA; OTCQX: VFORF), a technology company that has built and operates a cloud-based digital platform for online enthusiast communities, today announced financial results for the first quarter ended March 31, 2025 ("Q1" or "the quarter").
"In Q1, we navigated some challenges, including a more uncertain macro environment, softness in video advertising rates and recent changes to Google's search algorithm which affected traffic on Fora communities. As a result, revenue was 8% lower than prior year," said Rob Laidlaw, Founder, Chair and CEO of VerticalScope.
Mr. Laidlaw continued, "Like other user-generated platforms, we're adapting to an evolving search experience, one that requires optimizing our strategy for AI Overviews, and integrating our own proprietary AI-driven enhancements to improve engagement, accessibility and monetization over time. We are better equipped to handle these algorithm changes with the Fora platform, and the integration of AI, allowing us to roll out important upgrades very quickly. Despite the traffic volatility causing MAU's to be 8% lower in the quarter, we remain confident in our business model, the strength of our communities, and the long-term opportunities ahead."
Financial Highlights for the Three Months Ended March 31, 2025
Revenue decreased 8% to $13.6M. This decline was primarily driven by weaker performance in programmatic video ads and a slower start for direct advertising due to timing-related shifts in campaign launches.
Adjusted EBITDA decreased 30% to $3.6M, with a 27% Adjusted EBITDA Margin compared to 36% in the prior year, primarily driven by lower revenue and higher compensation and consulting costs, including strategic support for AI initiatives and SEO optimizations.
Operating Cash Flow was $3.0M, and Free Cash Flow was $3.1M, reflecting an 86% Free Cash Flow Conversion. During the quarter, we deployed $5.5M in capital towards acquisitions, adding 23 online communities to our platform.
Net loss increased by $1.4M to $2.4M, compared to a net loss of $1.0M in the prior year, resulting in a loss per share of $0.11. The increase was primarily driven by revenue declines and an $0.8M increase in share-based compensation, which included one-time performance-based incentives.
'While Q1 presented challenges on the top line, our disciplined approach continues to deliver strong cash flow,' said Vince Bellissimo, CFO of VerticalScope. 'We generated $3.0M in Operating Cash Flow and $3.1M in Free Cash Flow, with a healthy conversion rate of 86%. These results reflect our ability to navigate a shifting environment while investing in growth initiatives. We remain focused on disciplined capital allocation and will deploy capital toward opportunities that we believe will drive long-term shareholder value. Year-to-date we have deployed $7.3M in capital towards M&A, and approximately $1.8M towards repurchasing 516K shares under our NCIB.'
'We've completed four acquisitions so far in 2025, and the newly added communities are already seeing performance gains from our advertising technology and platform integration. With a strong balance sheet and proven playbook, we're well positioned to capitalize on market volatility and continue scaling through strategic M&A,' added Chris Goodridge, President and COO of VerticalScope.
Earnings Conference Call and Webcast
Management will host a conference call and webcast to discuss the Company's financial results at 8 a.m. ET on Wednesday, May 14, 2025.
Live Call Registration and Webcast:
https://events.q4inc.com/attendee/264422423
Joining Live by Telephone:
Canada: 1 833 950 0062
United States: 1 833 470 1428
Participant Access code: 610147
If you are unable to join live, an archived recording of the webcast will be available at: https://investors.verticalscope.com/.
About VerticalScope Holdings Inc.
Founded in 1999 and headquartered in Toronto, Ontario, VerticalScope is a technology company that has built and operates a cloud-based digital platform for online enthusiast communities in high consumer spending categories. VerticalScope's mission is to enable people with common interests to connect, explore their passions, and share knowledge about the things they love. Through targeted acquisitions and development, VerticalScope has built a portfolio of over 1,200 online communities and over 100 million monthly active users.
Forward-Looking Statements
This news release contains forward-looking information within the meaning of applicable securities legislation that reflects the Company's current expectations regarding future events. When used in this news release, words such as 'should', 'could', 'intended', 'expect', 'plan' or 'believe' and similar expressions indicate forward-looking statements. Forward-looking information, including the Company's plans for organic growth, deployment of capital, investments in our platform, the growth of revenue and MAU, information regarding our financial position, business strategy, growth strategies, addressable markets, budgets, operations, financial results, plans and objectives, is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond the Company's control. Although the Company believes that its expectations reflected in these forward-looking statements are reasonable, such statements involve risks and uncertainties and no assurances can be given that actual results will be consistent with these forward-looking statements. Such risks and uncertainties include, but are not limited to, the implementation and effectiveness of the Company's capital allocation strategy, the availability of high-quality M&A opportunities, and the factors discussed under "Risk Factors" in the Company's Annual Information Form dated April 1, 2024, which is available on the Company's profile on SEDAR Plus at https://sedarplus.ca. Actual results could differ materially from those projected herein. VerticalScope does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required under applicable securities laws.
Non-IFRS Measures
This press release references certain non-IFRS measures, including Adjusted EBITDA and Free Cash Flow, and Free Cash Flow Conversion as described below. This press release also makes reference to MAU, which is an operating metric used in our industry. These non-IFRS measures are not recognized measures under IFRS and do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of the Company's results of operations from management's perspective. Accordingly, these measures should not be considered in isolation nor as a substitute for analysis of the Company's financial information reported under IFRS.
The Company uses non-IFRS measures including:
'EBITDA' is calculated as net income (loss) excluding interest, income tax expense (recovery), and depreciation and amortization.
'Adjusted EBITDA' is calculated as EBITDA adjusted for share-based compensation, share performance related bonuses, unrealized gains or losses from changes in fair value of derivative financial instruments, severance, adjustments to contingent consideration liabilities measured at fair value through profit and loss, gain or loss on sale of assets, gain or loss on sale of investments, foreign exchange loss (gain), realized and unrealized other loss (gain), impairment and other charges that include direct and incremental business acquisition related costs.
'Adjusted EBITDA Margin' measures Adjusted EBITDA as a percentage of revenue.
'Free Cash Flow' means Adjusted EBITDA less capital expenditures and income taxes paid during the period.
'Free Cash Flow Conversion' is equal to Free Cash Flow for the period divided by Adjusted EBITDA for the period.
'Monthly Active Users' ('MAU') is defined as the number of individuals who have visited our communities within a calendar month, based on data as measured by Google Analytics. To calculate average MAU in a given period, we sum the total MAU for each month in that period, divided by the number of months in that period.
Related Links
The following table sets forth a reconciliation of Adjusted EBITDA and Free Cash Flow to net loss:
(1)
Share performance related bonus is included in wages and consulting on the condensed consolidated interim statements of loss and comprehensive loss.
(2)
Other charges are included in general and administrative on the condensed consolidated interim statements of loss and comprehensive loss. For the three months ended March 31, 2025 and March 31, 2024, these charges include non-recurring legal related costs.
Expand
VERTICALSCOPE HOLDINGS INC.
(In U.S. dollars, except per share amounts)
(Unaudited)
Three Months Ended
March 31,
2025
2024
Revenue
$13,565,517
$14,723,444
Operating expenses:
Wages and consulting
7,162,204
6,940,033
Share-based compensation
1,251,993
421,241
Platform and technology
1,639,598
1,543,535
General and administrative
1,060,465
1,192,625
Depreciation and amortization
4,423,575
4,564,628
15,537,835
14,662,062
Operating income (loss)
(1,972,318)
61,382
Other expenses (income):
Gain on sale of assets
(340)
(3,620)
Net interest and financing expense
747,818
1,162,932
Gain on sale of investments

(16,398)
Foreign exchange loss
55,655
27,380
Realized other loss
67,577

Unrealized other loss
26,453

897,163
1,170,294
Loss before income taxes
(2,869,481)
(1,108,912)
Income tax expense (recovery)
Current
411,484
88,618
Deferred
(865,456)
(212,937)
(453,972)
(124,319)
Net loss
($2,415,509)
($984,593)
Other comprehensive loss
Items that may be reclassified to net loss:
Foreign currency differences on translation of foreign operations

26,245
Total comprehensive loss
($2,415,509)
($958,348)
Loss per share:
Basic
($0.11)
($0.05)
Diluted
(0.11)
(0.05)
Expand
VERTICALSCOPE HOLDINGS INC.
Condensed Consolidated Interim Statements of Cash Flows
(In U.S. dollars)
(Unaudited)
Three months ended March 31
2025
2024
Cash provided by (used in):
Operating activities:
Net loss
($2,415,509)
($984,593)
Items not involving cash:
Depreciation and amortization
4,423,575
4,564,628
Net interest and financing expense
747,818
1,162,932
Gain on sale of assets
(340)
(3,620)
Gain on sale of investments

(16,398)
Unrealized loss (gain) in derivative instruments
(49,651)
55,668
Unrealized other loss
26,453

Income tax recovery
(453,972)
(124,319)
Share-based compensation
1,251,993
421,241
3,530,367
5,075,539
Change in non-cash operating assets and liabilities
235,553
1,443,964
Interest paid
(724,547)
(1,162,852)
Income taxes received (paid)
(75,030)
377,086
2,966,343
5,733,737
Financing activities:
Repayment of term loan

(625,000)
Proceeds from issuance of revolving loan
3,000,000

Repayment of revolving loan

(2,375,000)
Repurchase of share capital for cancellation

(233,226)
Lease payments
(323,279)
(360,982)
Proceeds from sublease
140,940
150,078
2,817,661
(3,444,130)
Investing activities:
Additions to property and equipment and intangible assets
(5,902,344)
(434,611)
Proceeds from sale of assets
340
4,114
Proceeds from sale of investments

16,398
(5,902,004)
(414,099)
Increase (decrease) in cash
(118,000)
1,875,508
Cash, beginning of period
5,189,315
6,015,184
Change in restricted cash balances
3,329
4,266
Effect of movement of exchange rates on cash and restricted cash held
(60,351)
13,078
Cash, end of period
$5,014,293
$7,908,036
Expand

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10th Anniversary Year of NAHYCO® Technology
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10th Anniversary Year of NAHYCO® Technology

Yahoo

time29 minutes ago

  • Yahoo

IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10th Anniversary Year of NAHYCO® Technology

IBSA Derma, the dermoaesthetic division of Swiss company IBSA, will participate in the 18th IMCAS Asia Congress in Bangkok, gathering over 3,000 professionals from across the region to explore the future of aesthetic and regenerative medicine. With the presence in the Congress and a dedicated scientific symposium, the company reaffirms its commitment to advancing bioremodeling approaches and promoting a holistic, science-driven vision of authentic beauty. This year marks a key milestone for IBSA Derma: 10 years of NAHYCO® Technology, a patented innovation in hyaluronic acid science that continues to shape the future of tissue regeneration. BANGKOK, June 06, 2025--(BUSINESS WIRE)--IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the latest innovations and cutting-edge advancements in aesthetic procedures and treatments, staying at the forefront of this dynamic field. As part of the congress, IBSA Derma will host a scientific symposium titled "The Future of Tissue Regeneration with NAHYCO® Technology. Feeling and Seeing the Results with Profhilo® Line" scheduled for Saturday, June 7, from 3:00 to 4:00 pm ICT in Room 1 - Level 2. Internationally renowned speakers – Dr. Lam Bee Lan and Prof. Ofir Artzi – will lead the session, focusing on the evolving approaches in regenerative aesthetic medicine, with particular attention to the clinical impact of hybrid cooperative complexes (HCCs) of hyaluronic acid and their role in tissue regeneration across different anatomical layers affected by aging. HCCs represent a new frontier in hyaluronic acid-based product formulation, made possible through NAHYCO® Technology, IBSA's patented thermal process that celebrates its 10th anniversary this year. This technological breakthrough is the foundation of the Profhilo® line and continues to be a milestone of IBSA Derma's innovation pathway. The Company's presence at IMCAS Asia is part of a broader strategic plan for expansion across the APAC region, an increasingly dynamic and high-potential market. In this context, IBSA Derma strengthened its regional presence last year with the opening of its regional hub in Singapore and the launch of a dedicated platform for Asian Key Opinion Leaders to share their clinical insights and expertise. "The strong growth we are experiencing in the APAC region stems from our solid collaboration with local distributors, which enable us to better understand the specific dynamics and cultural nuances of each market" – says Loy Derris, Business Development Director Dermoaesthetic Division North Asia. "Over the past 18 months, we have achieved remarkable results in countries such as Indonesia, Vietnam, Japan, and India, and we have recently entered the Thai market with great momentum. Looking ahead we are also looking enthusiastically toward promising new markets like Taiwan" – declares Magallon Riza Marie, Senior Strategic Marketing and Operational Lead Dermoaesthetic APAC Region. "Being at IMCAS Asia for the second year in a row is a valuable opportunity to strengthen our dialogue with physicians in the APAC Region and promote our concept of authentic beauty that embraces a holistic and overall wellness-oriented approach" – states Elisa Brozzelli, Brand Activation Manager Dermoaesthetic Division. IBSA Derma will also be present at Booth 8 - Level 2, where visitors can learn more about the latest solutions and innovations in aesthetic medicine. About IBSA IBSA (Institut Biochimique SA) is a Swiss pharmaceutical multinational with 20 subsidiaries across Europe, China, and the United States. Its products are available in over 90 countries, and its R&D activities focus on 10 therapeutic areas. In 2025, IBSA will celebrate the 40th anniversary of its acquisition by current President and CEO, Arturo Licenziati, who has transformed the company into a multinational corporation employing over 2,300 personnel worldwide. IBSA's growth and development can be attributed to its ability to innovate by refining well-known molecules, as well as to its commitment to looking to the future responsibly and transparently, thanks to the dedication and dynamism of its people. About IBSA Derma IBSA has used its experience and expertise in the pharmaceutical field to branch out and develop medical devices for aesthetic medicine based on hyaluronic acid, thus creating a dedicated division: IBSA Derma. Through scientific expertise, continuous research, technological development and a modern production process, IBSA has become one of the leading pharmaceutical companies to produce hyaluronic acid for aesthetic medicine applications. IBSA Derma distinguishes itself in this vast market because it controls the entire product lifecycle, from the biofermentation production of the raw material to the ready-to-use final product in prefilled syringes. View source version on Contacts For further information: Giulia Drei, PR and Communication SpecialistDermoaesthetic Sign in to access your portfolio

Western Exploration Announces Closing of Life Offering of Units for Gross Proceeds of C$5.0 Million
Western Exploration Announces Closing of Life Offering of Units for Gross Proceeds of C$5.0 Million

Yahoo

timean hour ago

  • Yahoo

Western Exploration Announces Closing of Life Offering of Units for Gross Proceeds of C$5.0 Million

Reno, Nevada--(Newsfile Corp. - June 6, 2025) - Western Exploration Inc. (TSXV: WEX) (OTCQX: WEXPF) (the "Company" or "Western Exploration") is pleased to announce that it has closed its previously announced "best efforts" private placement (the "Offering") for aggregate gross proceeds of C$5,005,000, which includes the full exercise of the agent's option. Under the Offering, the Company sold 7,150,000 units (the "Units") at a price of C$0.70 per Unit. Each Unit consists of one variable voting share of the Company and one-half of one variable voting share purchase warrant of the Company (each whole variable voting share purchase warrant, a " Warrant"). Each Warrant entitles the holder thereof to acquire one variable voting share of the Company (each, a "Warrant Share") at a price of C$0.95 per Warrant Share at any time until June 6, 2028, subject to adjustment in certain circumstances. The Offering was completed pursuant to the terms of an agency agreement dated June 6, 2025 between the Company and Red Cloud Securities Inc. (the "Agent"), as sole agent and bookrunner. The Company intends to use the net proceeds raised under the Offering for exploration and advancement of the Company's Aura Project located in Nevada, as well as for general corporate purposes and working capital. Darcy Marud, President and CEO of Western Exploration commented, "This financing enables us to take the next steps at Gravel Creek for resource expansion with an extensive drill program at Wood Gulch. This is the next step in growing Gravel Creek with additional high grade exploration targets." In consideration for the services provided by the Agent in connection with the Offering, the Company paid cash commission and advisory fees totaling C$280,325.01 and issued an aggregate of 400,464 non-transferable broker warrants (the "Broker Warrants") to the Agent. Each Broker Warrant is exercisable to acquire one variable voting share of the Company (each, a "Broker Warrant Share") at a price of C$0.70 per Broker Warrant Share at any time until June 6, 2028, subject to adjustment in certain circumstances. In addition, in consideration for the provision of certain finder services to the Company in connection with the Offering, the Company also paid certain parties an aggregate cash finder's fee of C$28,738.50 and issued an aggregate 41,055 finder's warrants (the "Finder's Warrants"). The Finder's Warrants were issued on substantially the same terms as the Broker Warrants. All Units distributed in connection with the Offering were issued and sold pursuant to the "Listed Issuer Financing Exemption" available under Part 5A of National Instrument 45-106 - Prospectus Exemptions (the "LIFE Exemption"), as amended by Coordinated Blanket Order 45-935 - Exemptions from Certain Conditions of the Listed Issuer Financing Exemption. A copy of the offering document under the LIFE Exemption dated May 21, 2025 (the "Offering Document") is available electronically on the Company's website and on SEDAR+ ( under the Company's issuer profile. Pursuant to the LIFE Exemption, all Units issued under the Offering are not subject to resale restrictions in Canada in accordance with applicable Canadian securities laws and the policies of the TSX Venture Exchange (the "Exchange"). All other securities not issued pursuant to the LIFE Exemption, namely, the Broker Warrants and Finders Warrants, are subject to a statutory hold period in accordance with applicable Canadian securities laws, expiring on October 7, 2025. The Offering remains subject to the final acceptance of the Exchange. MI 61-101 Disclosure Certain "insiders" of the Company have subscribed for an aggregate of 307,900 Units for aggregate gross proceeds of C$215,530, comprising (i) Darcy Marud, Chief Executive Officer, President and director of the Company, through the Marud-Rivas Trust, as to 179,400 Units for gross proceeds of C$125,580, (ii) Curtis Turner, Chief Financial Officer of the Company as to 28,500 Units for gross proceeds of C$19,950, and (iii) Gerard Munera, director of the Company, through Synergex Group LLC, as to 100,000 Units for gross proceeds of C$70,000. Each subscription by an "insider" of the Company is considered to be a "related party transaction" of the Company for purposes of Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101") and Section 5.9 - Protection of Minority Securityholders in Special Transactions of the Corporate Finance Manual of the TSX Venture Exchange. In completing the Offering, the Company is relying upon exemptions from the formal valuation and minority shareholder approval requirements available under MI 61-101. The Company is exempt from the formal valuation requirement in Section 5.4 of MI 61-101 in reliance on Sections 5.5(a) and (b) of MI 61-101 as the fair market value of the transaction, insofar as it involves interested parties, is not more than the 25% of the Company's market capitalization and no securities of the Company are listed or quoted for trading on prescribed stock exchanges or stock markets. Additionally, the Company is exempt from minority shareholder approval requirement in Section 5.6 of MI 61-101 in reliance on, inter alia, Section 5.7(a) as the fair market value of the transaction, insofar as it involves interested parties, is not more than the 25% of the Company's market capitalization. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. This news release shall not constitute an offer to sell or the solicitation of an offer to buy in the United States or to, or for the account or benefit of, persons in the United States or U.S. Persons nor shall there by any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. About Western Exploration Western Exploration is focused on advancing the 100% owned Aura Project, located approximately 120 kilometers/75 miles north of the city of Elko, Nevada. The Aura Project includes three unique gold and silver deposits: Doby George, Gravel Creek, and Wood Gulch. Western Exploration is comprised of an experienced team of precious metals experts that aim to lead the company to becoming North America's premiere gold and silver development company. Additional information regarding Western Exploration can be found on Western Exploration's corporate website ( and on SEDAR+ ( under Western Exploration's issuer profile. For further information, please contact: Darcy MarudChief Executive OfficerTelephone: (775) 329-8119Email: dmarud@ Nichole CowlesInvestor RelationsTelephone: (775) 240-4172Email: nicholecowles@ Cautionary Note Regarding Forward-Looking Information Certain statements contained in this news release may be deemed "forward‐looking statements" within the meaning of applicable Canadian and U.S. securities laws. These forward‐looking statements, by their nature, require Western Exploration to make certain assumptions and necessarily involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in these forward‐looking statements. Forward‐looking statements are not guarantees of performance. Words such as "may", "will", "would", "could", "expect", "believe", "plan", "anticipate", "intend", "estimate", "continue", or the negative or comparable terminology, as well as terms usually used in the future and the conditional, are intended to identify forward‐looking statements. This forward‐looking information is based on reasonable assumptions and estimates of management of the Company at the time such assumptions and estimates were made, and involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievement expressed or implied by such forward‐looking information. Such factors include, among others, risks relating to the receipt of final approval of the Offering by the Exchange and the intended use of the net proceeds of the Offering. Although the forward‐looking information contained in this news release is based upon what management believes, or believed at the time, to be reasonable assumptions, Western Exploration cannot assure shareholders and prospective purchasers of securities of the Company that actual results will be consistent with such forward‐looking information, as there may be other factors that cause results not to be as anticipated, estimated or intended, and neither Western Exploration nor any other person assumes responsibility for the accuracy and completeness of any such forward‐looking information. Further, Western Exploration does not undertake, and assumes no obligation, to update or revise any such forward-looking statements or forward‐looking information contained herein to reflect new events or circumstances, except as may be required by law. For additional information with respect to these and other factors and assumptions underlying the forward‐looking statements and forward-looking information made in this news release concerning Western Exploration, please refer to the continuous disclosure record of Western Exploration (including the Offering Document) on SEDAR+ ( under Western Exploration's issuer profile. The forward-looking statements set forth herein concerning Western Exploration reflect management's expectations as at the date of this news release and are subject to change after such date. Western Exploration disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, other than as required by law. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES To view the source version of this press release, please visit Sign in to access your portfolio

Simplify Healthcare's Benefits1™.Medicare Drives Over 30% of Nationwide PBP Submissions to CMS, Marking Over 7 Years as a Trusted Industry Leader
Simplify Healthcare's Benefits1™.Medicare Drives Over 30% of Nationwide PBP Submissions to CMS, Marking Over 7 Years as a Trusted Industry Leader

Yahoo

timean hour ago

  • Yahoo

Simplify Healthcare's Benefits1™.Medicare Drives Over 30% of Nationwide PBP Submissions to CMS, Marking Over 7 Years as a Trusted Industry Leader

AURORA, Ill., June 06, 2025--(BUSINESS WIRE)--Simplify Healthcare, a recognized leader in enterprise software solutions for Payers, proudly announces that its flagship platform, Benefits1™.Medicare, played a key role once again in streamlining over 30% of Medicare Advantage (MA) Plan Benefit Package (PBP) submissions to the Centers for Medicare & Medicaid Services (CMS) this year. This milestone highlights the platform's transformative impact on benefit plan management and its integral role in supporting Payers across the nation. Benefits1™.Medicare continues to be the industry leader, enabling large-scale CMS bid submissions successfully for over 7 years, while also importing data seamlessly from the CMS-PBP software. Designed to handle the complexities of bid submission and accessible immediately (benefit updates can be started at any time independent of HPMS releases), the platform continues to set the standard for speed, accuracy, and compliance in PBP submissions with its seamless integration, robust reporting, global data updates, secure user roles, workflow automation and audit tracking capabilities. "Our customers relied on Benefits1™.Medicare to streamline over 30% of nationwide PBP submissions—proof of the trust we've earned and the efficiency our platform delivers year after year." — Ramesh Padri, VP of Product Delivery at Simplify Healthcare. "Managing the full Medicare Advantage lifecycle—from bids to digital delivery—makes Benefits1™.Medicare truly stand out in helping Payers drive value and improve member experiences." — Tasneem Chital, VP of Government Markets at Simplify Healthcare. Industry Leadership Through Customer Focus As healthcare organizations face increasing operational and regulatory challenges, Benefits1™.Medicare offers an effective solution that simplifies workflows while driving greater organizational efficiency. "This milestone reflects our long-standing commitment of partnering with health plans to successfully manage bid submissions. We bring the full stack partnership experience — people, thought leaders, product, and technology— towards delivering a superior bid submission experience for our customers." — Nirnay Patel, EVP & GM of Benefits1™ at Simplify Healthcare. About Simplify Healthcare Simplify Healthcare powers connected benefits and provider journeys for Payers through a scalable, enterprise-grade, secure, compliant, and configurable cloud-based software platform — Simplify Health Cloud™. We offer highly scalable, technology-centered document and translation management services to Payers through Simplify Docs™. We also empower industries with AI-native SaaS solutions designed to build and deploy digital solutions faster, better, and with embedded AI through SimplifyX™. View source version on Contacts Simplify HealthcarePhone: (844) 720-6678Email: info@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store